Stoke Therapeutics Ownership | Who Owns Stoke Therapeutics?


OverviewForecastRevenueFinancialsChart

Stoke Therapeutics Ownership Summary


Stoke Therapeutics is owned by 103.33% institutional investors, 4.67% insiders. Skorpios trust is the largest institutional shareholder, holding 23.45% of STOK shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in Stoke Therapeutics shares.

STOK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockStoke Therapeutics103.33%4.67%-8.00%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Skorpios trust10.84M23.45%$146.50M
Blackrock5.41M11.70%$73.08M
Lynx1 capital management lp5.19M11.21%$70.05M
Redmile group4.72M10.21%$63.78M
Baker bros. advisors lp4.37M9.45%$59.02M
Rtw investments, lp4.22M9.14%$57.08M
Morgan stanley3.48M7.52%$47.00M
Cowen and company3.37M7.28%$45.47M
Vanguard group2.69M5.81%$36.31M
State street1.59M3.44%$21.50M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Skorpios trust10.84M99.89%$146.50M
Lynx1 capital management lp5.19M4.54%$70.05M
Redmile group4.72M3.86%$63.78M
Birchview capital, lp210.00K2.63%$2.84M
Cowen and company3.37M1.25%$45.47M
Rtw investments, lp4.22M0.88%$57.08M
Baker bros. advisors lp4.37M0.75%$59.02M
Dafna capital management207.43K0.67%$2.80M
Cormorant asset management, lp427.16K0.33%$5.77M
Granahan investment management598.40K0.32%$8.08M

Top Buyers

HolderShares% AssetsChange
Blackrock5.41M0.00%1.55M
Lynx1 capital management lp5.19M4.54%1.49M
State street1.59M0.00%1.01M
Baker bros. advisors lp4.37M0.75%1.00M
Marshall wace, llp1.16M0.02%982.45K

Top Sellers

HolderShares% AssetsChange
Skorpios trust10.84M99.89%-3.60M
Healthcare of ontario pension plan trust fund---1.39M
Logos global management lp---1.05M
Morgan stanley3.48M0.00%-546.21K
Deutsche bank ag\16.03K0.00%-396.21K

New Positions

HolderShares% AssetsChangeValue
Invesco437.14K0.00%437.14K$5.91M
Voloridge investment management198.28K0.01%198.28K$2.68M
Rafferty asset management79.89K0.00%79.89K$1.08M
Swiss national bank66.40K0.00%66.40K$897.06K
Ubs asset management americas57.40K0.00%57.40K$775.46K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-5.00
Quarry lp-118.00
Srs capital advisors-173.00
Lazard asset management-213.00
Pacer advisors-454.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241203.45%58,218,197-5.03%1030.59%61-25.61%3663.64%
Jun 30, 20241165.45%61,304,73913.13%1320.97%8217.14%22-15.38%
Mar 31, 202411032.53%54,189,69220.45%1171.17%70112.12%26-18.75%
Dec 31, 202383-17.00%44,987,6322.40%1001.02%33-23.26%32-11.11%
Sep 30, 2023100-5.66%43,931,099-5.62%990.89%43-20.37%3628.57%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.57M2.97%-
BlackRock Health Sciences Opps Inv A969.34K1.83%-
iShares Russell 2000 ETF953.19K1.80%-3.65K
BGF World Healthscience A2851.11K1.61%-
SPDR® S&P Biotech ETF765.79K1.45%-8.94K
Vanguard Institutional Extnd Mkt Idx Tr592.24K1.12%15.26K
BlackRock Health Sciences Term Trust530.09K1.00%-
M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc414.93K0.79%14.31K
Fidelity Small Cap Index365.16K0.69%2.11K
iShares Russell 2000 Growth ETF328.21K0.62%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 23, 2024Skorpios Trust-Sell$23.00M
Dec 09, 2024Ticho Barry CHIEF MEDICAL OFFICERSell$33.60K
Dec 09, 2024Allan Jonathan GENERAL COUNSEL & CORP SECSell$20.16K
Dec 09, 2024Allan Jonathan GENERAL COUNSEL & CORP SECSell$165.81K
Dec 09, 2024Kaye Edward M. MD CEOSell$88.16K

Insider Transactions Trends


DateBuySell
2024 Q4-10
2024 Q3-7
2024 Q2-11
2024 Q1-10
2023 Q4--

STOK Ownership FAQ


Who Owns Stoke Therapeutics?

Stoke Therapeutics shareholders are primarily institutional investors at 103.33%, followed by 4.67% insiders and -8.00% retail investors. The average institutional ownership in Stoke Therapeutics's industry, Biotech Stocks , is 109.70%, which Stoke Therapeutics falls below.

Who owns the most shares of Stoke Therapeutics?

Stoke Therapeutics’s largest shareholders are Skorpios trust (10.84M shares, 23.45%), Blackrock (5.41M shares, 11.70%), and Lynx1 capital management lp (5.19M shares, 11.21%). Together, they hold 46.36% of Stoke Therapeutics’s total shares outstanding.

Does Blackrock own Stoke Therapeutics?

Yes, BlackRock owns 11.70% of Stoke Therapeutics, totaling 5.41M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 73.08M$. In the last quarter, BlackRock increased its holdings by 1.55M shares, a 40.19% change.

Who is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested?

Skorpios trust is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested, with 99.89% of its assets in 10.84M Stoke Therapeutics shares, valued at 146.5M$.

Who is the top mutual fund holder of Stoke Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Stoke Therapeutics shares, with 2.97% of its total shares outstanding invested in 1.57M Stoke Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools